Cargando…
Viral vector-mediated downregulation of RhoA increases survival and axonal regeneration of retinal ganglion cells
The Rho/ROCK pathway is a promising therapeutic target in neurodegenerative and neurotraumatic diseases. Pharmacological inhibition of various pathway members has been shown to promote neuronal regeneration and survival. However, because pharmacological inhibitors are inherently limited in their spe...
Autores principales: | Koch, Jan Christoph, Tönges, Lars, Michel, Uwe, Bähr, Mathias, Lingor, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155783/ https://www.ncbi.nlm.nih.gov/pubmed/25249936 http://dx.doi.org/10.3389/fncel.2014.00273 |
Ejemplares similares
-
ROCKing Regeneration: Rho Kinase Inhibition as Molecular Target for Neurorestoration
por: Tönges, Lars, et al.
Publicado: (2011) -
Axonal degeneration as a therapeutic target in the CNS
por: Lingor, Paul, et al.
Publicado: (2012) -
ROCK2 is a major regulator of axonal degeneration, neuronal death and axonal regeneration in the CNS
por: Koch, J C, et al.
Publicado: (2014) -
Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson’s disease
por: Tönges, Lars, et al.
Publicado: (2012) -
Alpha-synuclein mutations impair axonal regeneration in models of Parkinson's disease
por: Tönges, Lars, et al.
Publicado: (2014)